[The experience with berodual inhalation in emergency treatment of bronchial asthma]. 1997

I V Leshchenko, and A V Bushuev, and A V Naumenko
Ural'skaia gosudarstvennaia meditsinskaia akademiia Minzdrava RF, MU "Skoraia meditsinskaia pomoshch", Ekaterinburg.

Of 56 patients with bronchial asthma demanding emergency care 27 had moderate exacerbation (group 1) and 29--a severe one (group 2). All the patients inhaled berodual (B) solution with a compressive pneumatic nebuliser Medic-Aide. The relief of the attack was achieved for 20 minutes of the inhalation in 22 and 19 patients of groups 1 and 2, respectively. Inhalation monotherapy with B solutions using a compressive nebuliser provides control of moderate and severe attacks of bronchial asthma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009241 Ipratropium A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. N-Isopropylatropine,(endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane,Atrovent,Ipratropium Bromide,Ipratropium Bromide Anhydrous,Ipratropium Bromide Monohydrate,Ipratropium Bromide, (endo,anti)-Isomer,Ipratropium Bromide, (exo,syn)-Isomer,Ipratropium Bromide, endo-Isomer,Itrop,Sch-1000,Sch-1178,N Isopropylatropine,Sch 1000,Sch 1178,Sch1000,Sch1178
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005260 Female Females
D005280 Fenoterol A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. Berotec,Berotek,Fenoterol Hydrobromide,Fenoterol Hydrochloride,Partusisten,Phenoterol,Th-1165a,p-Hydroxyphenyl-orciprenaline,p-Hydroxyphenylorciprenaline,Hydrochloride, Fenoterol,Th 1165a,Th1165a,p Hydroxyphenyl orciprenaline,p Hydroxyphenylorciprenaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

I V Leshchenko, and A V Bushuev, and A V Naumenko
January 1985, Sovetskaia meditsina,
I V Leshchenko, and A V Bushuev, and A V Naumenko
October 1978, Casopis lekaru ceskych,
I V Leshchenko, and A V Bushuev, and A V Naumenko
April 1983, Casopis lekaru ceskych,
I V Leshchenko, and A V Bushuev, and A V Naumenko
January 1997, Klinicheskaia meditsina,
I V Leshchenko, and A V Bushuev, and A V Naumenko
May 1946, New York state journal of medicine,
I V Leshchenko, and A V Bushuev, and A V Naumenko
February 1956, Svenska lakartidningen,
I V Leshchenko, and A V Bushuev, and A V Naumenko
January 1999, Klinicheskaia meditsina,
I V Leshchenko, and A V Bushuev, and A V Naumenko
February 1986, Deutsche medizinische Wochenschrift (1946),
I V Leshchenko, and A V Bushuev, and A V Naumenko
January 1976, Terapevticheskii arkhiv,
I V Leshchenko, and A V Bushuev, and A V Naumenko
January 1955, Therapie der Gegenwart,
Copied contents to your clipboard!